Immucell Corp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 5,397 | 3,533 | 3,447 | 3,911 | 4,796 |
| Cost of Goods | 4,130 | 2,489 | 3,146 | 2,919 | 2,950 |
| Gross Profit | 1,267 | 1,044 | 301 | 992 | 1,846 |
| Operating Expenses | 2,581 | 2,837 | 2,703 | 3,545 | 3,413 |
| Operating Income | -1,184 | -1,305 | -2,256 | -1,634 | -617 |
| Other Income | 244 | -74 | -58 | -33 | -34 |
| Pre-tax Income | -940 | -1,378 | -2,314 | -1,666 | -651 |
| Income Tax | 0 | 2 | 2 | 2 | 4 |
| Net Income Continuous | -940 | -1,380 | -2,315 | -1,668 | -655 |
| Net Income | $-940 | $-1,380 | $-2,315 | $-1,668 | $-655 |
| EPS Basic Total Ops | -0.12 | -0.18 | -0.30 | -0.22 | -0.08 |
| EPS Basic Continuous Ops | -0.12 | -0.18 | -0.30 | -0.22 | -0.08 |
| EPS Diluted Total Ops | -0.12 | -0.18 | -0.30 | -0.22 | -0.08 |
| EPS Diluted Continuous Ops | -0.12 | -0.18 | -0.30 | -0.22 | -0.08 |
| EBITDA(a) | $-475 | $-618 | $-1,597 | $-1,028 | $17 |